AR023873A1 - FORMULATION - Google Patents

FORMULATION

Info

Publication number
AR023873A1
AR023873A1 ARP000102193A ARP000102193A AR023873A1 AR 023873 A1 AR023873 A1 AR 023873A1 AR P000102193 A ARP000102193 A AR P000102193A AR P000102193 A ARP000102193 A AR P000102193A AR 023873 A1 AR023873 A1 AR 023873A1
Authority
AR
Argentina
Prior art keywords
formulation
edisilate
clomethiazole
methylthiazole
edisylate
Prior art date
Application number
ARP000102193A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR023873A1 publication Critical patent/AR023873A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulacion parenteral de edisilato de 5-(2-cloroetil)-4-metiltiazol (genéricamente conocido como edisilato de clometiazol) que tiene propiedadesantimicrobianas mejoradas además de estabilidad física, química y microbiologica como así también compatibilidad biologica.Parenteral formulation of 5- (2-chloroethyl) -4-methylthiazole edisylate (generically known as clomethiazole edisilate) that has improved antimicrobial properties in addition to physical, chemical and microbiological stability as well as biological compatibility.

ARP000102193A 1999-05-06 2000-05-05 FORMULATION AR023873A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901658A SE9901658D0 (en) 1999-05-06 1999-05-06 New formulation

Publications (1)

Publication Number Publication Date
AR023873A1 true AR023873A1 (en) 2002-09-04

Family

ID=20415507

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102193A AR023873A1 (en) 1999-05-06 2000-05-05 FORMULATION

Country Status (7)

Country Link
EP (1) EP1178798A1 (en)
JP (1) JP2002544164A (en)
AR (1) AR023873A1 (en)
AU (1) AU4792200A (en)
SE (1) SE9901658D0 (en)
TN (1) TNSN00094A1 (en)
WO (1) WO2000067753A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK733888A (en) * 1988-01-12 1989-07-13 Fujisawa Pharmaceutical Co stabilizer
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
SE8900564D0 (en) * 1989-02-17 1989-02-17 Astra Ab NOVEL MEDICINAL USE
SE9002659D0 (en) * 1990-08-15 1990-08-15 Astra Ab NEW PHARMACEUTICAL FORMULATIONS

Also Published As

Publication number Publication date
JP2002544164A (en) 2002-12-24
SE9901658D0 (en) 1999-05-06
EP1178798A1 (en) 2002-02-13
WO2000067753A1 (en) 2000-11-16
TNSN00094A1 (en) 2002-05-30
AU4792200A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
UY37994A (en) DNA MOLECULES CORRESPONDING TO THE MON88017 TRANSGENIC EVENT AND METHODS FOR THEIR DETECTION
HRP20070012A2 (en) Immunostimulatory oligonucleotide multimers
ATE330038T1 (en) NUCLEIC ACID BIOSENSOR
AR052980A1 (en) PREPARATION OF POLYMERIC DISPERSIONS OF ETHYLENE - NEUTRALIZED ACRYLIC ACID AND USE IN PRINTING MEDIA TO IMPROVE THE ADHESION OF DIGITAL ORGANIC PIGMENT
ATE548391T1 (en) CAPTIVE BINDING PROTEINS AS BIOSENSORS
CR8385A (en) PYRIMIDINES REPLACED WITH SULFOXIMIN AS INHIBITORS OF CDK AND / OR VEGF, ITS PREPARATION AND ITS USES AS A MEDICINAL PRODUCT
CN103667141B (en) A kind of Industrial sewage treatment agent
ECSP056111A (en) DERIVATIVES OF 2-ACILAMINO-4-FENILTIAZOL, ITS PREPARATION AND APPLICATION IN THERAPEUTICS
WO2005040317A3 (en) Fuel substance and associated cartridge for fuel cell
WO2008092041A3 (en) Optical biosensors
WO2005067498A3 (en) Bioreactor systems and disposable bioreactor
WO2009034927A1 (en) Cell culture instrument and cell culture method using the same
MXPA03005548A (en) Methods for the production of multimeric proteins, and related compositions.
DE502005002929D1 (en) ORAL PHARMACEUTICAL FORM CONTAINS PROBIOTIC BACTERIA
WO2004098634A3 (en) Protein arginine n-methyltransferase 2 (prmt-2)
BR0114199A (en) Nucleotide sequences measuring male fertility and methods of using them
ATE549041T1 (en) BACTERIA-BINDING WIPE
BRPI0416710A (en) composition and method for inhibiting the growth of microorganisms in noncellulosic fibers, noncellulosic fibers and use of the composition for inhibiting microorganism growth in noncellulosic fibers
CL2004000979A1 (en) NONAPEPTIDES CLOSED LYSOBACITINE TYPE, COMPOSITION THAT CONTAINS THEM PREPARATION METHOD, USED AS BACTERICIDE.
AR058185A1 (en) REAGENT FOR TEST SENSORS CONTAINING CELLULOSE POLYMERS
RS51896B (en) Glucosa isomerase for use in the treatment of fructose intolerance
BRPI0409326A (en) method for identifying and obtaining nucleic acids capable of modifying stress tolerance in plants
UY29163A1 (en) DERIVATIVES OF PIRIDINE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
AR023873A1 (en) FORMULATION
AR046843A1 (en) SILKED CARBOXAMIDS